Literature DB >> 32392493

Global Initiative for Asthma report: How will new recommendations affect practice in Canada?

Marie-France Beauchesne1, Catherine Lemiere2.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32392493      PMCID： PMC7207199          DOI： 10.1503/cmaj.191445

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  As-Needed Budesonide-Formoterol in Mild Asthma.

Authors:  Eric D Bateman; Helen K Reddel; J Mark FitzGerald
Journal:  N Engl J Med       Date:  2018-08-30       Impact factor: 91.245

2.  Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma.

Authors:  Richard Beasley; Mark Holliday; Helen K Reddel; Irene Braithwaite; Stefan Ebmeier; Robert J Hancox; Tim Harrison; Claire Houghton; Karen Oldfield; Alberto Papi; Ian D Pavord; Mathew Williams; Mark Weatherall
Journal:  N Engl J Med       Date:  2019-05-19       Impact factor: 91.245

3.  Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma.

Authors:  Paul M O'Byrne; Hans Bisgaard; Philippe P Godard; Massimo Pistolesi; Mona Palmqvist; Yuanjue Zhu; Tommy Ekström; Eric D Bateman
Journal:  Am J Respir Crit Care Med       Date:  2004-10-22       Impact factor: 21.405

4.  Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by a pMDI.

Authors:  E Seberová; A Andersson
Journal:  Respir Med       Date:  2000-06       Impact factor: 3.415

5.  Low-dose inhaled corticosteroids and the prevention of death from asthma.

Authors:  S Suissa; P Ernst; S Benayoun; M Baltzan; B Cai
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

6.  Assessing adherence to inhaled corticosteroids in asthma patients using an integrated measure based on primary and secondary adherence.

Authors:  Lucie Blais; Fatima-Zohra Kettani; Amélie Forget; Marie-France Beauchesne; Catherine Lemière; Francine M Ducharme
Journal:  Eur J Clin Pharmacol       Date:  2016-10-01       Impact factor: 2.953

7.  As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma.

Authors:  Eric D Bateman; Helen K Reddel; Paul M O'Byrne; Peter J Barnes; Nanshan Zhong; Christina Keen; Carin Jorup; Rosa Lamarca; Agnieszka Siwek-Posluszna; J Mark FitzGerald
Journal:  N Engl J Med       Date:  2018-05-17       Impact factor: 91.245

8.  The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma.

Authors:  William W Busse; Søren Pedersen; Romain A Pauwels; Wan C Tan; Yu-Zhi Chen; Carl Johan Lamm; Paul M O'Byrne
Journal:  J Allergy Clin Immunol       Date:  2008-04-11       Impact factor: 10.793

9.  A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists.

Authors:  S Suissa; P Ernst; J F Boivin; R I Horwitz; B Habbick; D Cockroft; L Blais; M McNutt; A S Buist; W O Spitzer
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405
  9 in total
  2 in total

1.  Dry powder inhalers are environmentally preferable to metered-dose inhalers.

Authors:  Kimberly Wintemute; Fiona Miller
Journal:  CMAJ       Date:  2020-07-20       Impact factor: 8.262

2.  Impact of Inhaled and Intranasal Corticosteroids Exposure on the Risk of Ocular Hypertension and Glaucoma: A Systematic Review and Meta-Analysis.

Authors:  Anastasiya Vinokurtseva; Matthew Fung; Erica Ai Li; Richard Zhang; James J Armstrong; Cindy M L Hutnik
Journal:  Clin Ophthalmol       Date:  2022-05-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.